GB2187191B - Protection of proteins and the like - Google Patents
Protection of proteins and the likeInfo
- Publication number
- GB2187191B GB2187191B GB8704890A GB8704890A GB2187191B GB 2187191 B GB2187191 B GB 2187191B GB 8704890 A GB8704890 A GB 8704890A GB 8704890 A GB8704890 A GB 8704890A GB 2187191 B GB2187191 B GB 2187191B
- Authority
- GB
- United Kingdom
- Prior art keywords
- proteins
- protection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Vascular Medicine (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8704890A GB2187191B (en) | 1984-01-30 | 1986-07-09 | Protection of proteins and the like |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57509184A | 1984-01-30 | 1984-01-30 | |
GB858517352A GB8517352D0 (en) | 1985-07-09 | 1985-07-09 | Protection of proteins |
GB868613066A GB8613066D0 (en) | 1986-05-29 | 1986-05-29 | Protection of proteins &c |
GB8704890A GB2187191B (en) | 1984-01-30 | 1986-07-09 | Protection of proteins and the like |
PCT/GB1986/000396 WO1987000196A1 (en) | 1985-07-09 | 1986-07-09 | Protection of proteins and the like |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8704890D0 GB8704890D0 (en) | 1987-04-08 |
GB2187191A GB2187191A (en) | 1987-09-03 |
GB2187191B true GB2187191B (en) | 1989-11-01 |
Family
ID=27449677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8704890A Expired GB2187191B (en) | 1984-01-30 | 1986-07-09 | Protection of proteins and the like |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2187191B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7744925B2 (en) | 1994-12-02 | 2010-06-29 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
US8168223B1 (en) | 1997-09-29 | 2012-05-01 | Novartis Pharma Ag | Engineered particles and methods of use |
US8709484B2 (en) | 2000-05-10 | 2014-04-29 | Novartis Ag | Phospholipid-based powders for drug delivery |
US9439862B2 (en) | 2000-05-10 | 2016-09-13 | Novartis Ag | Phospholipid-based powders for drug delivery |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5059518A (en) * | 1988-10-20 | 1991-10-22 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
US6190701B1 (en) | 1999-03-17 | 2001-02-20 | Peter M. Ronai | Composition and method for stable injectable liquids |
GB2350046B (en) | 1999-05-20 | 2002-12-18 | British Sugar Plc | Edible compositions containing trehalose |
GB2498774A (en) | 2012-01-27 | 2013-07-31 | Bruce Roser | Glass-stabilised biological materials and syringe |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1855591A (en) * | 1926-02-03 | 1932-04-26 | Wallerstein Co Inc | Invertase preparation and method of making the same |
FR2406999A1 (en) * | 1977-10-27 | 1979-05-25 | Behringwerke Ag | STABILIZER FOR MENINGOCOCCAL POLYSACCHARIDES |
GB2016687A (en) * | 1978-03-20 | 1979-09-26 | Abbott Lab | Sugar Coated Reagents for Solid Phase Immunoassay |
FR2532178A1 (en) * | 1982-08-31 | 1984-03-02 | Asahi Chemical Ind | PROCESS FOR STABILIZING TUMOR NECROSIS FACTOR AND AQUEOUS SOLUTION OR STABLE POWDER CONTAINING THE SAME |
EP0111216A2 (en) * | 1980-03-31 | 1984-06-20 | Takeda Chemical Industries, Ltd. | Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor |
EP0140489A1 (en) * | 1983-08-05 | 1985-05-08 | Wako Pure Chemical Industries, Ltd. | Method for stabilizing immunologically active substances immobilized on an insoluble carrier and their use in the preparation of reagents for measuring physiologically active substances |
-
1986
- 1986-07-09 GB GB8704890A patent/GB2187191B/en not_active Expired
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1855591A (en) * | 1926-02-03 | 1932-04-26 | Wallerstein Co Inc | Invertase preparation and method of making the same |
FR2406999A1 (en) * | 1977-10-27 | 1979-05-25 | Behringwerke Ag | STABILIZER FOR MENINGOCOCCAL POLYSACCHARIDES |
GB2009198A (en) * | 1977-10-27 | 1979-06-13 | Behringwerke Ag | Stabilized polysaccharides |
GB2016687A (en) * | 1978-03-20 | 1979-09-26 | Abbott Lab | Sugar Coated Reagents for Solid Phase Immunoassay |
EP0111216A2 (en) * | 1980-03-31 | 1984-06-20 | Takeda Chemical Industries, Ltd. | Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor |
FR2532178A1 (en) * | 1982-08-31 | 1984-03-02 | Asahi Chemical Ind | PROCESS FOR STABILIZING TUMOR NECROSIS FACTOR AND AQUEOUS SOLUTION OR STABLE POWDER CONTAINING THE SAME |
GB2126588A (en) * | 1982-08-31 | 1984-03-28 | Asahi Chemical Ind | A method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing the same |
EP0140489A1 (en) * | 1983-08-05 | 1985-05-08 | Wako Pure Chemical Industries, Ltd. | Method for stabilizing immunologically active substances immobilized on an insoluble carrier and their use in the preparation of reagents for measuring physiologically active substances |
Non-Patent Citations (1)
Title |
---|
Patent Abstracts of Japan,Volume 9,No.323 JP A 60149972 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7744925B2 (en) | 1994-12-02 | 2010-06-29 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
US7780991B2 (en) | 1994-12-02 | 2010-08-24 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
US7785631B2 (en) | 1994-12-02 | 2010-08-31 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
US8168223B1 (en) | 1997-09-29 | 2012-05-01 | Novartis Pharma Ag | Engineered particles and methods of use |
US8709484B2 (en) | 2000-05-10 | 2014-04-29 | Novartis Ag | Phospholipid-based powders for drug delivery |
US9439862B2 (en) | 2000-05-10 | 2016-09-13 | Novartis Ag | Phospholipid-based powders for drug delivery |
Also Published As
Publication number | Publication date |
---|---|
GB2187191A (en) | 1987-09-03 |
GB8704890D0 (en) | 1987-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3666855D1 (en) | Alcalisilicate compositions and their use | |
GB8412564D0 (en) | Structure and properties | |
IL78934A0 (en) | Alfuzosine compositions and use | |
ZA859339B (en) | Processes and compositions | |
GB2176489B (en) | Polypeptide and polypeptide composition | |
GR860078B (en) | Spiro - dioxolanes - dithiolanes and oxothiolanes | |
EP0214102A3 (en) | 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions | |
ZA857124B (en) | 13-halomilbemycins and 13-hydroxymilbemycins | |
GB2164044B (en) | -hanp related polypeptides and their use | |
GB2168065B (en) | Polyanhydride-siloxanes and polyimide-siloxanes obtained therefrom | |
GB2159160B (en) | Mercaptocycloalkylcarbonyl and mercaptoarylcarbonyl dipeptides | |
DE3565257D1 (en) | Hydroxyalkylcycloalkylbenzeneacetamides and benzamides | |
EP0165753A3 (en) | Herbicidal thiophenesulfonamides and pyridinesulfonamides | |
ZA853379B (en) | Substituted 1-oxa-dethiachphalosporins as anti-inflammatory and antidegenerative agents | |
GB2187191B (en) | Protection of proteins and the like | |
DE3562486D1 (en) | Arginyl-3-carboxy-4-hydroxyanilide and their use | |
EP0230052A3 (en) | Immunoamplifiers and related compositions | |
ZA855612B (en) | N-arylsulfonyl-n'-triazinylureas and n-arylsulfonyl-n'-pyrimidinyl-ureas | |
DE3563624D1 (en) | Novel substituted trifluorooxetane and preparation thereof | |
AU4617185A (en) | Ketofin and anti-asthmatically effective xanthine | |
AU568750B2 (en) | Imidazo-pyrrolo-pyridines and their use as herbacides | |
EP0162690A3 (en) | 2-oxa-spirocyclic-benzeneacetamides and benzamides | |
GB8820199D0 (en) | Protective materials and application thereof | |
PH20880A (en) | Substituted benzoxepines and isochromanes | |
GB8414999D0 (en) | Protection of surfaces |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
708B | Proceeding under section 8(1) patents act 1977 | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
775O | Application for amendment (sect. 75/1977) open to opposition | ||
775L | Amendment of patent in infringement or revocation proceedings. application to amend not proceeded with (sect. 75/1977) | ||
775L | Amendment of patent in infringement or revocation proceedings. application to amend not proceeded with (sect. 75/1977) | ||
SP | Amendment (slips) printed | ||
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 20060708 |